Atrys Health (XMAD:ATRY) Institutional Ownership: 4.12% (As of Jul. 07, 2026)


XMAD:ATRY Atrys Health SA XMAD:ATRY
66 GF Score
Price €2.57
GF Value €3.13
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Atrys Health Institutional Ownership?

Atrys Health XMAD:ATRY -0.39% 66 Institutional Ownership is 4.12% as of Jul. 07, 2026. GuruFocus rates XMAD:ATRY with a GF Score™ of 66/100 and a GF Value™ of €3.13 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Atrys Health's institutional ownership is 4.12%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Atrys Health's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Atrys Health's Float Percentage Of Total Shares Outstanding is 0.00%.

Atrys Health Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Atrys Health's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atrys Health Institutional Ownership Chart

Atrys Health Historical Data

The historical data trend for Atrys Health can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 3.14 3.14 3.60 4.17 3.92 3.88 4.16 4.17 4.13 4.12
XMAD:ATRY
66GF Score
Atrys Health SA XMAD:ATRY
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atrys Health Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 4.12% mean?
Atrys Health (XMAD:ATRY) has a Institutional Ownership of 4.12% as of Jul. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Atrys Health and its competitors.
Is Atrys Health's Institutional Ownership too high?
Atrys Health's current Institutional Ownership is 4.12%. Overall, Atrys Health has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Atrys Health's Institutional Ownership compare to VRTX and REGN?
Atrys Health's Institutional Ownership of 4.12% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Atrys Health and its competitors. Atrys Health's current Institutional Ownership is 4.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atrys Health stock overvalued right now?
Based on GuruFocus' analysis, Atrys Health (XMAD:ATRY) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.13, compared to a current price of €2.57 — trading 18.1% below its estimated fair value. The current Institutional Ownership is 4.12%. Atrys Health's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Atrys Health (XMAD:ATRY), the current Institutional Ownership is 4.12% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Atrys Health (XMAD:ATRY) Overvalued in 2026?

Based on GuruFocus' analysis, Atrys Health stock appears to be undervalued. The current stock price of €2.57 is trading 18.1% below its estimated GF Value™ of €3.13. GuruFocus considers Atrys Health to be Modestly Undervalued.

Key valuation signals for XMAD:ATRY:

  • Institutional Ownership: 4.12%
  • GF Value™: €3.13 vs. price of €2.57 (18.1% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the XMAD:ATRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Atrys Health Business Description

Other Exchanges A2T:Germany
Address Calle Provenca, 392 planta baja, Barcelona, ESP, 08025
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.
66GF Score

Get the complete analysis for XMAD:ATRY

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.57
Price
€3.13
GF Value